====== THZ1 0.06μM R08 exp531 ====== ==== Mechanism of Action ==== Inhibits CDK7, forms covalent adduct, blocks phosphorylation of the C-terminal domain of RNA polymerase II * **Class / Subclass 1:** Gene Regulation / Transcription Inhibitor * **Class / Subclass 2:** Signal Transduction / Kinase Inhibitor ==== Technical Notes ==== * **PubChem Name:** %%THZ1 Hydrochloride%% * **Synonyms:** N/A * **CAS #:** N/A * **PubChem CID:** [[https://pubchem.ncbi.nlm.nih.gov/compound/78358326|78358326]] * **IUPAC:** %%N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]phenyl]-4-[[(E)-4-(dimethylamino)but-2-enoyl]amino]benzamide;hydrochloride%% * **INCHI Name:** InChI=1S/C31H28ClN7O2.ClH/c1-39(2)16-6-11-28(40)35-21-14-12-20(13-15-21)30(41)36-22-7-5-8-23(17-22)37-31-34-19-26(32)29(38-31)25-18-33-27-10-4-3-9-24(25)27;/h3-15,17-19,33H,16H2,1-2H3,(H,35,40)(H,36,41)(H,34,37,38);1H/b11-6+; * **INCHI Key:** LSAGMHUBJCPLJS-ICSBZGNSSA-N * **Molecular Weight:** 602.5 * **Canonical SMILES:** CN(C)CC=CC(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl.Cl * **Isomeric SMILES:** CN(C)C/C=C/C(=O)NC1=CC=C(C=C1)C(=O)NC2=CC=CC(=C2)NC3=NC=C(C(=N3)C4=CNC5=CC=CC=C54)Cl.Cl * **Molecular Formula:** C31H29Cl2N7O2 {{:chemogenomics:structures:chem-0335.svg?nolink}} * **Supplier Name:** Med Chem Express * **Catalog #:** HY-80013A * **Lot #:** 25842 * **HRMS (ESI-TOF) m/z:** (M+H)+ Calcd for C31H28ClN7O2 566.20658; found 566.20799 * **Platform ID:** THZ1 * **Min:** -3.2339; **Max:** 99.8907 {{:chemogenomics:dose_response:dr_588.png?nolink&500 |}} \\ \\ \\ \\ |< 300px 100px 200px >| ^ IC ^ Concentration (µM) ^ | IC10 |0.0053 | | IC20 |0.0131 | | IC30 |0.0240 | | IC40 |0.0394 | | IC50 |0.0622 | | IC60 |0.0981 | | IC70 |0.1612 | | IC80 |0.2954 | | IC90 |0.7349 | \\ ==== Screen Summary ==== * **Round**: 08 * **Dose**: 60nM * **Days of incubation**: 8 * **Doublings**: -0.3 * **Numbers of reads**: 16956922 ==== Screen Results ==== ^Sensitive/Resistant hits (FDR<0.05)^CRANKS^Score Plot^Top 30 Genes^Screen Similarity^Top 30 Sensitive GO terms^Top 30 Resistant GO terms^ |0/42|[[https://files.tyerslab.com/files/public/chemogenomics/cranks/THZ1_0.06uM_Round-8_exp531.txt|Scores]]|||||| {{:chemogenomics:cranks_plots:exp531.png?nolink}} ^Gene^CRANKS Score^FDR^ |[[:human_genes:W:WDR61|WDR61]]|-2.73|0.28| |[[:human_genes:P:POLD2|POLD2]]|-2.69|0.28| |[[:human_genes:F:FANCI|FANCI]]|-2.63|0.28| |[[:human_genes:G:GOLGA6L1|GOLGA6L1]]|-2.56|0.53| |[[:human_genes:N:NCLN|NCLN]]|-2.54|0.28| |[[:human_genes:P:PSMA1|PSMA1]]|-2.45|0.29| |[[:human_genes:E:EXOSC4|EXOSC4]]|-2.40|0.29| |[[:human_genes:A:ATP6V1A|ATP6V1A]]|-2.34|0.29| |[[:human_genes:U:UBA1|UBA1]]|-2.34|0.52| |[[:human_genes:S:SPI1|SPI1]]|-2.34|0.28| |[[:human_genes:R:RPS9|RPS9]]|-2.28|0.53| |[[:human_genes:H:HIST1H4E|HIST1H4E]]|-2.26|0.28| |[[:human_genes:T:TAF9|TAF9]]|-2.24|0.28| |[[:human_genes:A:ABCA13|ABCA13]]|-2.23|0.29| |[[:human_genes:F:FAM186A|FAM186A]]|-2.21|0.29| |[[:human_genes:C:CFLAR|CFLAR]]|-2.20|0.28| |[[:human_genes:C:CMC2|CMC2]]|-2.18|0.51| |[[:human_genes:C:CDC73|CDC73]]|-2.17|0.36| |[[:human_genes:Z:ZNF121|ZNF121]]|-2.17|0.28| |[[:human_genes:C:CHD8|CHD8]]|-2.16|0.28| |[[:human_genes:B:BCOR|BCOR]]|-2.15|0.28| |[[:human_genes:F:FADS6|FADS6]]|-2.14|0.39| |[[:human_genes:C:CDCA8|CDCA8]]|-2.14|0.51| |[[:human_genes:T:TRIM36|TRIM36]]|-2.12|0.29| |[[:human_genes:T:TAS2R60|TAS2R60]]|-2.09|0.29| |[[:human_genes:U:UBXN1|UBXN1]]|-2.08|0.41| |[[:human_genes:P:PASD1|PASD1]]|-2.08|0.29| |[[:human_genes:F:FPR2|FPR2]]|-2.06|0.36| |[[:human_genes:S:SART1|SART1]]|-2.06|0.53| |[[:human_genes:I:IL12A|IL12A]]|-2.06|0.29| |[[:human_genes:A:ATP5B|ATP5B]]|2.51|0.01| |[[:human_genes:T:TAZ|TAZ]]|2.51|0.15| |[[:human_genes:C:CDH22|CDH22]]|2.52|0.02| |[[:human_genes:P:PARL|PARL]]|2.56|0.02| |[[:human_genes:T:THG1L|THG1L]]|2.60|0.01| |[[:human_genes:D:DOHH|DOHH]]|2.60|0.02| |[[:human_genes:M:MARCH5|MARCH5]]|2.60|0.02| |[[:human_genes:C:C10orf12|C10orf12]]|2.64|0.02| |[[:human_genes:M:MLST8|MLST8]]|2.70|<0.01| |[[:human_genes:T:TTI2|TTI2]]|2.73|0.01| |[[:human_genes:H:HSPD1|HSPD1]]|2.74|<0.01| |[[:human_genes:T:TP53|TP53]]|2.84|<0.01| |[[:human_genes:T:TTI1|TTI1]]|2.84|<0.01| |[[:human_genes:G:GNB1L|GNB1L]]|2.87|<0.01| |[[:human_genes:F:FBXO11|FBXO11]]|2.88|<0.01| |[[:human_genes:M:MED23|MED23]]|2.88|<0.01| |[[:human_genes:C:CASP9|CASP9]]|2.97|<0.01| |[[:human_genes:V:VDAC2|VDAC2]]|3.13|<0.01| |[[:human_genes:A:ALAS1|ALAS1]]|3.13|0.01| |[[:human_genes:M:MTOR|MTOR]]|3.15|<0.01| |[[:human_genes:K:KMT2D|KMT2D]]|3.16|<0.01| |[[:human_genes:R:RPTOR|RPTOR]]|3.17|<0.01| |[[:human_genes:T:TELO2|TELO2]]|3.26|<0.01| |[[:human_genes:C:CYCS|CYCS]]|3.41|<0.01| |[[:human_genes:A:ATP5J|ATP5J]]|3.53|<0.01| |[[:human_genes:H:HCCS|HCCS]]|3.94|<0.01| |[[:human_genes:A:APAF1|APAF1]]|4.18|<0.01| |[[:human_genes:G:GMPPB|GMPPB]]|4.74|<0.01| |[[:human_genes:B:BAK1|BAK1]]|5.68|<0.01| |[[:human_genes:B:BEND3|BEND3]]|7.22|<0.01| ^Screen^Correlation^Plot^ |[[:results:exp527|Tanespimycin 14μM R08 exp527]]|0.089|| |[[:results:exp532|TIC10 10μM R08 exp532]]|0.06|| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|0.053|| |[[:results:exp529|Thimerosal 0.85μM R08 exp529]]|0.052|| |[[:results:exp478|Doxorubicin 0.02μM R08 exp478]]|0.146|| |[[:results:exp443|SNS-032 15μM R08 exp443]]|0.146|| |[[:results:exp459|Bleomycin 5μM R08 exp459]]|0.142|| |[[:results:exp456|Benzoate 20000μM R08 exp456]]|0.136|| |[[:results:exp2|5-Fluorouracil 20μM R00 exp2]]|0.128|| |[[:results:exp28|Pimelic-diphenylamide-106 5μM R00 exp28]]|0.124|| |[[:results:exp503|Mitomycin-C 0.06μM R08 exp503]]|0.12|| |[[:results:exp472|CI-1040 9.5μM R08 exp472]]|0.112|| |[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|0.106|| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|0.103|| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|0.099|| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|0.096|| |[[:results:exp22|MLN-4924 2μM R00 exp22]]|0.096|| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|0.095|| |[[:results:exp135|MS023 7μM R03 exp135]]|0.094|| |[[:results:exp80|RO-3307 4.7μM R02 exp80]]|0.093|| |[[:results:exp34|Rotenone 20μM R00 exp34]]|0.093|| |[[:results:exp488|Hippuristanol 0.12μM R08 exp488]]|0.093|| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|0.091|| |[[:results:exp211|AICAR 240μM R05 exp211]]|0.09|| |[[:results:exp515|PU-H71 1μM R08 exp515]]|0.089|| |[[:results:exp435|JQ1 0.8μM R08 exp435]]|0.086|| |[[:results:exp19|Etoposide 1μM R00 exp19]]|0.081|| |[[:results:exp96|BI-2536 0.02μM R03 exp96]]|0.078|| |[[:results:exp474|CR131-b 0.005μM R08 exp474]]|0.077|| |[[:results:exp524|Staurosporine 0.02μM R08 exp524]]|0.077|| |[[:results:exp487|Hinokiflavone 12μM R08 exp487]]|0.075|| |[[:results:exp17|DABN 20μM R00 exp17]]|0.074|| |[[:results:exp512|Olaparib 4μM R08 exp512]]|0.074|| |[[:results:exp134|MS023 2μM R03 exp134]]|0.064|| |[[:results:exp448|Ammonium tetrathiomolybdate 10μM R08 exp448]]|0.062|| |[[:results:exp126|GSK461364A 0.1μM R03 exp126]]|0.062|| |[[:results:exp98|BI-6727 0.04μM R03 exp98]]|0.062|| |[[:results:exp485|GSK626616 14μM R08 exp485]]|0.061|| |[[:results:exp539|42°C R08 exp539]]|0.059|| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|0.057|| |[[:results:exp441|GSK-J4 1.5μM R08 exp441]]|0.057|| |[[:results:exp517|Quercetin 20μM R08 exp517]]|0.055|| |[[:results:exp93|DABN racemic mixture R03 exp93]]|0.053|| |[[:results:exp357|Dorsomorphin 5μM R07 exp357]]|0.052|| {{:chemogenomics:comparison_plots:exp527_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp531_vs_exp532.png?nolink |}} {{:chemogenomics:comparison_plots:exp106_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp529_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp478_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp443_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp459_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp456_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp2_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp28_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp503_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp472_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp3_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp199_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp451_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp259_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp22_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp440_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp135_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp531_vs_exp80.png?nolink |}} {{:chemogenomics:comparison_plots:exp34_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp488_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp489_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp211_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp515_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp435_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp19_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp531_vs_exp96.png?nolink |}} {{:chemogenomics:comparison_plots:exp474_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp524_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp487_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp17_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp512_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp134_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp448_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp126_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp531_vs_exp98.png?nolink |}} {{:chemogenomics:comparison_plots:exp485_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp531_vs_exp539.png?nolink |}} {{:chemogenomics:comparison_plots:exp500_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp441_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp517_vs_exp531.png?nolink |}} {{:chemogenomics:comparison_plots:exp531_vs_exp93.png?nolink |}} {{:chemogenomics:comparison_plots:exp357_vs_exp531.png?nolink |}} No GO term hits below threshold. (FDR <0.05) ^GO Term^Fold Change^Genes^ |apoptosome|552.30|APAF1,CASP9| |positive regulation of pentose-phosphate shunt|552.30|RPTOR,MLST8| |TTT complex|552.30|TELO2,TTI1| |TORC1 complex|441.84|TELO2,MTOR,TTI1,MLST8| |regulation of pentose-phosphate shunt|368.20|RPTOR,MTOR,TP53,MLST8| |activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c|331.38|APAF1,CYCS,CASP9| |regulation of NADP metabolic process|315.60|RPTOR,MTOR,TP53,MLST8| |TOR complex|276.15|TELO2,RPTOR,MTOR,TTI1,MLST8| |TORC2 complex|276.15|TELO2,MTOR,TTI1,MLST8| |rDNA binding|165.69|BEND3,RPTOR,MTOR| |TORC1 signaling|150.63|RPTOR,MTOR,MLST8| |positive regulation of purine nucleotide metabolic process|129.95|BEND3,RPTOR,MTOR,MLST8| |positive regulation of nucleotide metabolic process|129.95|BEND3,RPTOR,MTOR,MLST8| |regulation of purine nucleotide metabolic process|65.75|BEND3,RPTOR,MTOR,TP53,MLST8| |regulation of nucleotide metabolic process|64.22|BEND3,RPTOR,MTOR,TP53,MLST8| |apoptotic mitochondrial changes|39.45|BAK1,VDAC2,TP53,HSPD1| |positive regulation of cysteine-type endopeptidase activity|22.45|BAK1,APAF1,CYCS,CASP9,HSPD1| |mitochondrial membrane|9.40|BAK1,HCCS,ATP5PF,CYCS,MTOR,ALAS1,VDAC2,HSPD1,MARCHF5,THG1L,PARL,ATP5F1B| |mitochondrial envelope|8.83|BAK1,HCCS,ATP5PF,CYCS,MTOR,ALAS1,VDAC2,HSPD1,MARCHF5,THG1L,PARL,ATP5F1B|